Structures of β1-adrenergic receptor in complex with Gs and ligands of different efficacies

G-protein-coupled receptors (GPCRs) receive signals from ligands with different efficacies, and transduce to heterotrimeric G-proteins to generate different degrees of physiological responses. Previous studies revealed how ligands with different efficacies activate GPCRs. Here, we investigate how a GPCR activates G-proteins upon binding ligands with different efficacies. We report the cryo-EM structures of beta(1)-adrenergic receptor (beta(1)-AR) in complex with Gs (G alpha(s)G beta(1)G gamma(2)) and a partial agonist or a very weak partial agonist, and compare them to the beta(1)-AR-Gs structure in complex with a full agonist. Analyses reveal similar overall complex architecture, with local conformational differences. Cellular functional studies with mutations of beta(1)-AR residues show effects on the cellular signaling from beta(1)-AR to the cAMP response initiated by the three different ligands, with residue-specific functional differences. Biochemical investigations uncover that the intermediate state complex comprising beta(1)-AR and nucleotide-free Gs is more stable when binding a full agonist than a partial agonist. Molecular dynamics simulations support the local conformational flexibilities and different stabilities among the three complexes. These data provide insights into the ligand efficacy in the activation of GPCRs and G-proteins. Su et al. report cryo-EM structures of beta(1)-adrenergic receptor, Gs and ligands of different efficacies. These complexes have similar overall architecture, but with local conformational differences and different stabilities.

Automated summary

This study investigates how a GPCR activates G-proteins upon binding ligands with different efficacies. Cryo-EM structures of beta(1)-adrenergic receptor (beta(1)-AR) in complex with Gs and ligands of different efficacies were reported. The complexes have similar overall architecture but with local conformational differences and different stabilities. Cellular and biochemical studies show the effects of ligand efficacy on the cellular signaling from beta(1)-AR to the cAMP response.